Nazanene Helen Esfandiari, MD is a Clinical Associate Professor in the Division of Metabolism, Endocrinology and Diabetes. Dr. Esfandiari received her medical degree from the University of Bordeaux II, Bordeaux, France. She completed her Internal Medicine Residency in France and then again at U MASS Memorial Health Center, Worcester, MA. She then completed her fellowship training in endocrinology at the University of Michigan. In 2003, Dr. Esfandiari joined the faculty of the University of Michigan
Dr. Esfandiari’s practice focuses on thyroid cancer, thyroid nodules, thyroid disorders, Post Bariatric patients and general endocrinology. She is also interested in Hyperglycemia Inpatient Insulin Program (HIIP). She sees patients at the University of Michigan Comprehensive Cancer Center, Brighton Health Center and Metabolism, Endocrinology & Diabetes (MEND) Clinic at Domino's Farms. She received an award in Clinical Excellence.
Dr. Esfandiari is a Co-director of M2 Endocrine Sequences at the Medical School. She also teaches first-, second- and third-year medical students as well as residents and fellows. She also participates in few retrospective clinical studies. She is a Co-Investigator in PERL study; an NIH founded research; where the effect of Allopurinol is tested in patient with type 1 diabetes and elevated urine microalbumin.